Alto Neuroscience, Inc. (ANRO) vs City Therapeutics, Inc (CTY)

Alto Neuroscience, Inc. ANRO 25.16 +15.04%
City Therapeutics, Inc CTY 18.56 +8.73%

Alto Neuroscience, Inc. and City Therapeutics, Inc are both Biotechnology companies. Alto Neuroscience, Inc. and City Therapeutics, Inc are of similar size ($882.9M and $858.2M).

Metric	ANRO	CTY	Biotechnology median
P/E	n/m	—	10.60
P/S	n/m	—	9.40
P/B	4.91	—	2.13
Price to free cash flow	n/m	—	25.18
EV/EBITDA	n/m	—	0.66
EV/Sales	n/m	—	9.02
Earnings yield	(9.62%)	—	(32.88%)
Free cash flow yield	(6.39%)	—	(23.13%)

Metric	ANRO	CTY	Biotechnology median
Gross margin	—	—	68.51%
Operating margin	0.00%	—	0.00%
Net margin	0.00%	—	0.00%
Free cash flow margin	0.00%	—	0.00%
Return on equity	(49.17%)	—	(51.96%)
Return on assets	(40.90%)	—	(46.06%)
Return on invested capital	0.00%	—	0.00%

Metric	ANRO	CTY	Biotechnology median
Revenue growth (TTM)	—	—	6.76%
EPS growth (last fiscal year)	12.40%	—	29.88%
Revenue growth, 5-year CAGR	—	—	9.75%
Net income growth, 5-year CAGR	—	—	0.00%

Metric	ANRO	CTY	Biotechnology median
Debt to equity	0.09	—	0.00
Current ratio	14.85	—	4.97
Net debt to EBITDA	2.40	—	1.01

Metric	ANRO	CTY	Biotechnology median
Dividend yield	—	—	0.41%
Payout ratio	—	—	—

Metric	ANRO	CTY	Biotechnology median
Market cap	858.22m	882.88m	161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack